Renal Cancer - Results from #3380

Systematic Review and Pooled Analysis of the Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial Nephrectomy. August 27, 2019

Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. August 27, 2019

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors. August 27, 2019

Poor Outcomes with the Use of Checkpoint Inhibitors in Kidney Transplant Recipients. August 27, 2019

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. August 26, 2019

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. August 26, 2019

Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma. August 26, 2019

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium. August 26, 2019

First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma. August 23, 2019

Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study. August 23, 2019

Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity. August 23, 2019

Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. August 22, 2019

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments. August 22, 2019

Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors. August 22, 2019

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study. August 21, 2019

How Does Treatment Uncertainty Factor into Decisions to Place Patients on Active Surveillance for Kidney Cancer? August 21, 2019

Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database. August 20, 2019

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. August 20, 2019

Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies. August 20, 2019

Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma. August 19, 2019

Page 170 of 457